Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mycobacterial protein synthesis enzymes are essential components of the translational machinery in Mycobacterium species, including the pathogen Mycobacterium tuberculosis (M. tuberculosis). These enzymes catalyze key steps in translating genetic information into functional proteins, making them critical for bacterial survival and growth. One well-studied example is phenylalanyl-tRNA synthetase, which charges tRNA molecules with phenylalanine. These enzymes are attractive targets for new antibiotics because they are essential for bacterial survival and have structural differences from human homologs, allowing selective inhibition. Recent research has also identified toxins like TacT that block mycobacterial protein synthesis, and detoxifying enzymes that reverse these modifications, representing novel vulnerabilities within mycobacteria's proteostasis network. Classic antibiotics such as chloramphenicol and kanamycin inhibit ribosomal activity directly.
Inhibition of protein synthesis
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterial Protein Synthesis Enzyme.